Jamie Otremba – OB Medication Update: The Latest Pharmacological Options for Pregnancy and Birth – PESI

*** Proof of Product ***

---

Exploring the Essential Features of “Jamie Otremba – OB Medication Update: The Latest Pharmacological Options for Pregnancy and Birth – PESI”

Speaker: Jamie Otremba, MSN, RN, CNM
Format : Video
Media Type: Digital Seminar 

Description
There have been big changes in everything from FDA medication labeling, recommendations for treating many of the major complications of pregnancy, and Covid 19 infection in pregnancy.

Jamie Otremba, MSN, RN, CNM, a practicing full scope nurse-midwife with extensive maternal child nursing experience, will break down the latest recommendations for the safest, most effective drugs to treat pregnant and laboring patients to improve outcomes, reduce risk, and improve patient satisfaction.   

You will take away the necessary tools to reduce complications related to Covid-19 in pregnancy. Did you know that recent Covid-19 infection is a contraindication to some drugs? Or that the thresholds and medications to treat pregnant patients with Covid-19 are different? Update your Covid-19 understanding on the vaccines, fetal and maternalnewborn transmission, when and how to treat, when to consider ventilation, and talking points for a quick and effective conversation.

But that’s not all! Jamie will also deliver the latest from evidence on over-the counter products that patients are using, hemorrhagic prevention and the best meds to treat the ‘Top 10’ pregnancy indications seen your own practice!

Speaker
Jamie Otremba, MSN, RN, CNM, has over 25 years of maternal child nursing experience and is currently practicing full-scope nurse-midwifery at a progressive OB/GYN clinic in suburban Minnesota. Jamie has been active in program development and benchmarking in both clinic and hospital settings. She is also one of the medical directors for the Women’s and Children’s Service Line at a large hospital and medical center in Minnesota. Jamie served as an assistant professor at Minnesota State University and has practiced in women’s health care in a variety of settings, including labor and delivery, postpartum, antenatal, and community health nursing.

She has consulted area healthcare facilities on clinical and legal practice topics, and she continues as an investigator for several medication trials pertinent to obstetric and gynecologic issues. Additionally, Jamie has enjoyed sharing her vast knowledge and experiences as a preceptor for both medical and advanced practice nursing students. Her goal is to provide you with the latest pharmacological options for pregnancy and birth to ultimately improve the maternal and fetal outcomes of your own patients.

Speaker Disclosures:
Financial: Jamie Otremba has an employment relationship with Allina Health and receives compensation as a national speaker. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Jamie Otremba is a member of the American College of Nurse-Midwives and the Network for LGBT Health Equity.

Objectives

1. Evaluate the new FDA pregnancy safety labeling information to treatment conversations with pregnant patients.
2. Analyze evidence-based recommendations for the best medication options to treat pregnant patients, while considering gestational age and comorbidities.
3. Analyze safety of patient’s pre-pregnancy medications in pregnancy.
4. Develop a plan of care with pregnant patients, to pharmacologically manage pregnancy complications, considering safety, alternatives, risk, benefit.
5. Distinguish between risks of Covid 19 infection and vaccine in pregnant women.
6. Assess medication appropriateness for a patient with a Covid 19 infection in pregnancy.
7. Develop a nonbiased dialogue for discussing vaccines in pregnancy.
8. Evaluate patient’s pain control needs and apply evidence-based recommendations for narcotic alternatives.
    

Outline

New FDA Pregnancy Safety Labeling

• Risk summary explained
• Examples

Teratogenicity

• Highest risk medications
• Historical poor outcomes
• Risk reduction strategies

Top 10 Pregnancy Indications & Medications to Treat

• How to decide on safest, most effective option
• Current preferred drugs for each diagnosis
• Consenting the patient
• Preexisting diagnosis
  Depression/anxiety preferred medications
  Asthma/allergies
  Chronic hypertension, including new BP parameters & rational for treatment Pregnancy complications
  Nausea/vomiting: New FDA approved medications, when you need IV treatment &what to use
  Gestational diabetes: oral medications vs insulin & best insulin formulations in pregnancy
  GI reflux: If not Zantac—what’s next?
  Insomnia: OTC and prescription medication compatible with pregnancy
  Vaginitis: Safest medication by gestational age
  Pain: Including opioid prescription reduction strategies
  Preterm labor: Prevention mediation recommendations just changed

Vaccines in Pregnancy

• Latest info on pros, cons & safety
• Pearls on quick but effective patient teaching/interactions
• Flu shot
• TDAP
• Covid 19 vaccine

Latest Labor and Delivery Medications News

• VTE prevention and Covid 19: Aspirin, lovenox, heparin- when, how much, how long
• Hemorrhage prevention and Covid 19: to TXA or not to TXA
• Treatments for pregnant women with Covid 19
  Medications
  Monoclonal antibodies
  Ventilation

Over-the-Counter Products in Pregnancy

• Overview of uses and safety
• Essential oils: Routes, indications, evidence on effectiveness
• Homeopathics
• Supplements

Putting It All Together

• Case Studies
• Healthcare Provider/ Patient Resource List

Target Audience
Health care providers who work with childbearing aged women, pregnant women, and on labor and delivery. Appropriate for nurses, nurse practitioners, nurse midwives, family practice providers. Both inpatient and outpatient information will be addressed.

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/